Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ZNTL - Zentalis Pharmaceuticals promotes co-founder Kevin Bunker to chief scientific officer

ZNTL - Zentalis Pharmaceuticals promotes co-founder Kevin Bunker to chief scientific officer

Zentalis Pharmaceuticals Inc.
  • Clinical-stage biopharma Zentalis Pharmaceuticals ( NASDAQ: ZNTL ) on Tuesday said it had appointed its co-founder Kevin Bunker as chief scientific officer.
  • "In this new role, (Bunker) will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine," the company said in a statement .
  • Bunker had previously been chief operating officer at the company.
  • ZNTL stock earlier closed +3.8% at $21.

For further details see:

Zentalis Pharmaceuticals promotes co-founder Kevin Bunker to chief scientific officer
Stock Information
Company Name: Zentalis Pharmaceuticals Inc.
Stock Symbol: ZNTL
Market: NASDAQ
Website: zentalis.com
Menu
ZNTL ZNTL Quote ZNTL Short ZNTL News ZNTL Articles ZNTL Message Board
Get ZNTL Alerts

News, Short Squeeze, Breakout and More Instantly...